文献速递乳腺癌放疗放疗物理与技术

可解释深度学习洞见:揭示1 Gy体积在乳腺癌放疗后淋巴细胞减少中的作用

Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancer.
PubMed 文献 · Radiother Oncol · 2024-05-19

这项多中心研究纳入918例接受辅助放疗的浸润性乳腺癌患者,利用剂量体积直方图数据和临床因素构建密集神经网络模型预测放疗后淋巴细胞减少。研究发现包括1 Gy体积在内的几乎所有剂量水平体积均为显著预测因子,最终模型预测准确率达75%以上,并强调V1的重要性值得特别关注。

要点

  • 乳腺癌辅助放疗后淋巴细胞减少的预测中,几乎所有剂量水平的治疗体积均为显著预测因子,包括1 Gy体积(V1)。
  • 最终密集神经网络模型结合危及器官全剂量体积参数和三个关键临床因素,预测准确率达75%以上。
  • 现代VMAT放疗技术下V1值常相对较高,V1的重要性值得特别关注。

核心结论

  • 该研究证实并外部验证了全剂量数据,特别是关键结构低至1 Gy的低剂量体积对乳腺癌患者放疗后淋巴细胞减少的重要性。
  • V1的重要性值得特别关注,因为现代VMAT放疗技术下该参数值常相对较高。
  • 需要进一步研究以优化放疗计划。

研究设计与样本

  • 多中心研究,纳入918例接受辅助放疗的浸润性乳腺癌患者。
  • 训练集589例、测试集203例、外部验证集126例。
  • 研究终点为淋巴细胞减少,定义为放疗后绝对淋巴细胞减少及分级淋巴细胞减少。
  • 采用危及器官剂量体积直方图数据和临床因素构建密集神经网络预测模型,并用外部患者队列验证。

主要发现

  • 几乎所有剂量水平的治疗体积均为放疗后淋巴细胞减少的显著预测因子,包括肺、心脏和身体的1 Gy体积(V1),尤其是同侧肺V1。
  • 最终密集神经网络模型结合危及器官全剂量体积参数和三个关键临床因素,预测准确率达75%以上。

局限性

  • 需要进一步研究以优化放疗计划。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Lymphopenia is known for its significance on poor survivals in breast cancer patients. Considering full dosimetric data, this study aimed to develop and validate predictive models for lymphopenia after radiotherapy (RT) in breast cancer. MATERIAL AND METHODS: Patients with breast cancer treated with adjuvant RT were eligible in this multicenter study. The study endpoint was lympopenia, defined as the reduction in absolute lymphocytes and graded lymphopenia after RT. The dose-volume histogram (DVH) data of related critical structures and clinical factors were taken into account for the development of dense neural network (DNN) predictive models. The developed DNN models were validated using external patient cohorts. RESULTS: A total of 918 consecutive patients with invasive breast cancer enrolled. The training, testing, and external validating datasets consisted of 589, 203, and 126 patients, respectively. Treatment volumes at nearly all dose levels of the DVH were significant predictors for lymphopenia following RT, including volumes at very low-dose 1 Gy (V1) of organs at risk (OARs) including lung, heart and body, especially ipsilateral-lung V1. A final DNN model, combining full DVH dosimetric parameters of OARs and three key clinical factors, achieved a predictive accuracy of 75 % or higher. CONCLUSION: This study demonstrated and externally validated the significance of full dosimetric data, particularly the volume of low dose at as low as 1 Gy of critical structures on lymphopenia after radiation in patients with breast cancer. The significance of V1 deserves special attention, as modern VMAT RT technology often has a relatively high value of this parameter. Further study is warranted for RT plan optimization.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Chen F, Zhou P, Ren G, et al. Interpretable deep learning insights: Unveiling the role of 1 Gy volume on lymphopenia after radiotherapy in breast cancer. Radiother Oncol. 2024. PMID: 38772478. doi:10.1016/j.radonc.2024.110333

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。